author-photo

Urvashi V. Roongta

Bristol-Myers Squibb

9

Papers

525

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Mo1881 – Multiomics Analysis of IBD Endoscopic Biopsies Reveal Cd8 T Cells As Potential Disease Biomarkers

2019 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Erratum: N-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent(Journal of Medicinal Chemistry (2004) 47 (1719-1728) DOI: 10.1021/jm0305568)

2015 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 5417: The identification of BMS-595, an orally active imidazo[1,2-b]pyridazine CK2 inhibitor with in vivo anti-tumor activity

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 4115: Depletion of unsaturated fatty acids by stearoyl-coA desaturase inhibition results in endoplasmic reticulum stress-mediated tumor cell death

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy

2011 Molecular Cancer Research
Show All
- Source
- Cite
- Save
Citations (161)
Abstract C62: Cancer cell dependence on unsaturated fatty acids implicates stearoyl-coA desaturase as a target for cancer therapy

2011 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
N-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent

2004 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (221)